Dry eye in 2008

Current Opinion in Ophthalmology

Volumn 20, Issue 4, 2009, Pages 282-286

  Abelson, Mark B ^a,b   Ousler III, George W ^a   Maffei, Ciera ^a  

^a Ora Inc   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Dry eye; Keratoconjunctivitis sicca; Tear film; Tears

Indexed keywords

12 SULFODEHYDROABIETIC ACID; ANTIINFLAMMATORY AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DOXYCYCLINE; HYALURONIC ACID; LINOLENIC ACID; LX 214; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 ANTAGONIST; OMEGA 6 FATTY ACID; REBAMIPIDE; RX 10045; UNCLASSIFIED DRUG; VOCLOSPORIN;

BLINKING; CIRCADIAN RHYTHM; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRY EYE; EYELID; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; TEAR FILM;

AGE FACTORS; ANTERIOR EYE SEGMENT; CIRCADIAN RHYTHM; CYTOKINES; DRY EYE SYNDROMES; EYELIDS; HUMANS; OPHTHALMIC SOLUTIONS; SEX FACTORS; TEARS;

EID: 67651050049     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32832b7578     Document Type: Review

References (34)

1. Brewitt H, Sistani F. Dry eye disease: the scale of the problem. Surv Ophthalmol 2001; 45 (Suppl 2):S199-S202. (Pubitemid 33052378)
2. Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci 2008; 85:668-674.
3. Ousler GW, Gomes PJ, Welch D, Abelson MB. Methodologies for the study of ocular surface disease. Ocul Surf 2005; 3:143-154. (Pubitemid 41269396)
4. Caffery B, Joyce E, Boone A, et al. Tear lipocalin and lysozyme in Sjö gren and non-Sjö gren dry eye. Optom Vis Sci 2008; 85:661-667.
5. Wolfe F, Michaud K. Prevalence, risk, and risk factors for oral and ocular dryness with particular emphasis on rheumatoid arthritis. J Rheumatol 2008; 35:1023-1030; Epub 2008 May 15. Ocular and oral dryness are prevalent in rheumatoid arthritis patients and appear to be associated with duration of disease and therapy.
6. Villani E, Galimberti D, Viola F, et al. Corneal involvement in rheumatoid arthritis: an in vivo confocal study. Invest Ophthalmol Vis Sci 2008; 49:560-564.
7. Polanská V, Serý O, Fojtík Z, Hlinomazová Z. The presence of dry eye syndrome and corneal complications in patients with rheumatoid arthritis and its association with -174 gene polymorphism for interleukin 6 [in Czech]. Cesk Slov Oftalmol 2008; 64:77-80.
8. Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol 2008; 8:10. Dry eye is prevalent in patients with type II diabetes and assessments for dry eye should be performed regularly in diabetic patients.
9. Rocha EM, Cunha DA, Carneiro EM, et al. Identification of insulin in the tear film and insulin receptor and IGF-I receptor on the human ocular surface. Invest Ophthalmol Vis Sci 2002; 43:963-967. (Pubitemid 34258262)
10. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008; 17:350-355.
11. Guillon M, Maissa C. Contact lens wear affects tear film evaporation. Eye Contact Lens 2008; 34:326-330. Increased tear evaporation rates occur in eyes wearing contact lenses than eyes of contact lens wearers without lenses and eyes of nonwearers. Relative humidity changes affect these rates and these results may implicate increased evaporation as a contributing factor in dry eye experienced by contact lens wearers.
12. Ramamoorthy P, Sinnott LT, Nichols JJ. Treatment, material, care, and patientrelated factors in contact lens-related dry eye. Optom Vis Sci 2008; 85:764-772.
13. Ozkan J, Papas E. Lubricant effects on low Dk and silicone hydrogel lens comfort. Optom Vis Sci 2008; 85:773-777.
14. Kato N, Toda I, Hori-Komai Y, et al. Five-year outcome of LASIK for myopia. Ophthalmology 2008; 115:839-844; Epub 2007 Sept 27.
15. Konomi K, Chen LL, Tarko RS, et al. Preoperative characteristics and a potential mechanism of chronic dry eye after LASIK. Invest Ophthalmol Vis Sci 2008; 49:168-174. Reduced preoperative tear volume may predispose patients to chronic dry eye post-LASIK.
16. Barequet IS, Hirsch A, Levinger S. Effect of thin femtosecond LASIK flaps on corneal sensitivity and tear function. J Refract Surg 2008; 24:897-902.
17. Butovich IA. On the lipid composition of human meibum and tears: comparative analysis of nonpolar lipids. Invest Ophthalmol Vis Sci 2008; 49:3779- 3789; Epub 2008 May 16.
18. Butovich IA, Millar TJ, Ham BM. Understanding and analyzing meibomian lipids - a review. Curr Eye Res 2008; 33:405-420; Epub 2008 May 1. Recognition of the interaction between the meibum and proteins in the tear film is increasingly important.
19. Shen M, Wang J, Tao A, et al. Diurnal variation of upper and lower tear menisci. Am J Ophthalmol 2008; 145:801-806; Epub 2008 Mar 4.
20. Schindelar MR, Prifogle E, Ousler GW, et al. Diurnal variations in symptoms of dry eye [E-abstract 5319]. Invest Ophthalmol Vis Sci 2008; 49. Varied diurnal patterns of symptomatology exist in dry eye patients and may translate to different pathophysiologies.
21. Workman DA, Wilcox-Hagberg K, Ousler GW III, et al. Diurnal signs and symptoms associated with dry eye [E-abstract 278]. Invest Ophthalmol Vis Sci 2006; 47.
22. Paulsen F, Jä ger K, Worlitzsch D, et al. Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines. Ann Anat 2008; 190:59-70.
23. Narayanan S, Corrales RM, Farley W, et al. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye. Cornea 2008; 27:811-817.
24. Joffre C, Souchier M, Gré goire S, et al. Differences in meibomian fatty acid composition in patients with meibomian gland dysfunction and aqueousdeficient dry eye. Br J Ophthalmol 2008; 92:116-119.
25. Abelson MB, Doane MG, Ousler G. Tear film and blink dynamics. In: Albert DM, Miller JW, editors. Albert & Jakobiec's principles and practice of ophthalmology, 3rd edition Canada: Saunders; 2008. p. 281.
26. Ousler GW 3rd, Hagberg KW, Schindelar M, et al. The Ocular Protection Index. Cornea 2008; 27:509-513. The OPI offers a binomial parameter denoting the level of ocular surface protection provided by the tear film between blinks. The OPI is a unique endpoint for dry eye treatment.
27. Casavant J, OuslerGWIII, Wilcox Hagberg K, et al. A correlation between the signs and symptoms of dry eye and the duration of dry eye diagnosis [E-abstract 4455]. Invest Ophthalmol Vis Sci 2005; 46.
28. Smith J, Nichols KK, Baldwin EK. Current patterns in the use of diagnostic tests in dry eye evaluation. Cornea 2008; 27:656-662. It is increasingly important to recognize both the signs and symptoms of dry eye. Use of subjective assessments for symptoms and completion of a comprehensive medical history should be performed in conjunction with clinical tests for objective signs of dry eye.
29. Srinivasan S, Joyce E, Senchyna M, et al. Clinical signs and symptoms in postmenopausal females with symptoms of dry eye. Ophthalmic Physiol Opt 2008; 28:365-372. (Pubitemid 351847256)
30. Simpson TL, Situ P, Jones LW, Fonn D. Dry eye symptoms assessed by four questionnaires. Optom Vis Sci 2008; 85:E692-E699. Different questionnaires successfully separate symptomatic patients from asymptomatic patients and results suggest the potential usefulness of a short questionnaire in screening dry eye patients.
31. Miljanovic B, Trivedi KA, Dana MR, et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 2005; 82:887-893. (Pubitemid 43779705)
32. Pratt SG, Ousler GW, Schindelar M, et al. Evaluation of a novel dry eye oral supplement for the treatment of the signs and symptoms of dry eye in the controlled adverse environment [E-abstract 2047]. Invest Ophthalmol Vis Sci 2005; 46.
33. Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye 2008; 31:141-146; Epub 2008 Mar 4.
34. Rashid S, Jin Y, Ecoiffier T, et al. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008; 126:219-225. Topical application of a-linolenic acid may be beneficial in patients with dry eye.